Literature DB >> 7044631

Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid.

M E Medof, J P Antel, J J Oger, G M Prince, B G Arnason.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7044631      PMCID: PMC1536559     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  26 in total

1.  Mechanism of binding of soluble immune complexes to lymphocytes.

Authors:  A Eden; C Bianco
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid.

Authors:  E B Keeffe; E J Bardana; R J Harbeck; B Pirofsky; R I Carr
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

4.  The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.

Authors:  P J Lachmann; H J Müller-Eberhard
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

5.  C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

6.  Complement factors in multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

Review 7.  Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus.

Authors:  L D Petz; G C Sharp; N R Cooper; W S Irvin
Journal:  Medicine (Baltimore)       Date:  1971-07       Impact factor: 1.889

8.  Complement-dependent release of immune complexes from the lymphocyte membrane.

Authors:  G W Miller; P H Saluk; V Nussenzweig
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

9.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.

Authors:  A N Theofilopoulos; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.